High-Resolution PET Imaging for Head and Neck Cancer
Recruiting in Palo Alto (17 mi)
ER
Overseen byEben Rosenthal, Ph.D
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Stanford University
No Placebo Group
Trial Summary
What is the purpose of this trial?
This trial is testing a new PET scan machine that takes very detailed pictures to help doctors see head and neck cancers more clearly.
Research Team
ER
Eben Rosenthal, Ph.D
Principal Investigator
Stanford Universiy
Eligibility Criteria
This trial is for adults 19 years or older with a biopsy-confirmed diagnosis of head and neck cancer (HNC), who are scheduled for surgery and a PET/CT scan. It's not suitable for those with conditions that could affect their participation as judged by the study leader.Inclusion Criteria
I am scheduled for surgery for head and neck cancer.
Scheduled to have a PET/CT study on a conventional PET/CT system
My diagnosis of head and neck cancer was confirmed by a biopsy.
See 1 more
Exclusion Criteria
Additional condition, or extenuating circumstance that, in the opinion of the investigator, may interfere with study compliance.
Treatment Details
Interventions
- 1-mm Resolution Clinical PET camera (Imaging Device)
Trial OverviewThe trial is testing a new PET camera system with 1-mm resolution to evaluate its image quality in diagnosing HNC, compared to conventional PET/CT systems, within a clinical setting.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Novel PET CameraExperimental Treatment1 Intervention
Patients already undergoing a PET/CT scan for HNC will afterwards undergo a PET scan with the proposed device, thus no additional radioactivity is needed as part of this study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Trials
2,527
Recruited
17,430,000+
Dr. Richard A. Miller
Stanford University
Chief Executive Officer since 2023
Stanford University, MD
Dr. Robert Schott
Stanford University
Chief Medical Officer since 2021
University of Michigan, MD
Emerson Collective
Collaborator
Trials
3
Recruited
700+
Goldman Sachs Foundation
Collaborator
Trials
1
Recruited
10+
Wallace H. Coulter Foundation
Collaborator
Trials
14
Recruited
1,300+